| Identification | Back Directory | [Name]
Benzenesulfonamide, 2-fluoro-5-methyl-4-[methyl[(3R)-1-(phenylmethyl)-3-pyrrolidinyl]amino]-N-4-thiazolyl- | [CAS]
2154408-63-4 | [Synonyms]
XEN901
Benzenesulfonamide, 2-fluoro-5-methyl-4-[methyl[(3R)-1-(phenylmethyl)-3-pyrrolidinyl]amino]-N-4-thiazolyl- | [Molecular Formula]
C22H25FN4O2S2 | [MOL File]
2154408-63-4.mol | [Molecular Weight]
460.59 |
| Hazard Information | Back Directory | [Biological Activity]
NBI-921352 (XEN901) is a potent inhibitor of sodium channels, specially targeting Nat/1.6 channels. NBI-921352 (XEN901) treats the nervous system pathologies of epilepsy effectively without adverse side effects (extracted from patent WO2017201468A1)[1]. | [storage]
Store at -20°C | [References]
[1]. Jean-Christophe ANDREZ, et al. Benzenesulfonamide compounds and their use as therapeutic agents. Patent WO2017201468A1. |
|
| Company Name: |
DC Chemicals
|
| Tel: |
021-58447131 13564518121 |
| Website: |
http://m.is0513.com/ShowSupplierProductsList927327/0.htm |
|